Global Stem Cell Market Projected to Reach $18.7 Billion by 2025, Growing at 11.1% CAGR

Global stem cells market was valued at $18.7 billion in 2025 and is growing at a CAGR of 11.1% during the forecast period (2026-2035). Chronic diseases, such as heart disease, diabetes, and neurodegenerative disorders, are a major focus for stem cell research because they often involve the damage or loss of cells and tissues. Stem cells offer potential for repairing or replacing these damaged cells, supporting tissue regeneration, and developing personalized therapies. This makes them a promising avenue for addressing the long-term impacts of chronic conditions.

Browse the full report description of “Global Stem Cell and Platelet Rich Plasma Alopecia Therapies Market Size, Share And Trend Analysis Report By Treatment (Platelet Rich Plasma Therapies and Stem Cell Therapy), By End-User (Hospitals, Dermatology Clinics, And Others) Forecast (2025-2035)” at https://www.omrglobal.com/industry-reports/stem-cell-and-platelet-rich-plasma-alopecia-therapies-market

Moreover, chronic diseases such as heart disease, cancer, and diabetes are increasing globally, resulting in a greater demand for advanced therapies such as stem cell treatments that are fueling market growth. As per the Centers for Disease Control and Prevention (CDC), Gov., in August 2025, chronic diseases like heart disease, cancer, and diabetes are the primary causes of death and disability in the US, contributing to the nation's $4.9 trillion in annual healthcare costs. Approximately 75% of American adults have at least one chronic condition, with rates increasing among older populations. Specifically, cancer diagnoses stand at 1.8 million annually, leading to over 600,000 deaths, while diabetes affects more than 38 million individuals, incurring an estimated $413 billion in costs in 2022 due to medical expenses and lost productivity. The cost of cancer care is projected to exceed $240 billion by 2030, while diabetes poses serious health risks, including heart disease and kidney failure.

Leading Companies Advancing the Stem Cell Market

Major players in the stem cell industry include Lonza Group, Merck KGaA, Sartorius AG, STEMCELL Technologies, and Thermo Fisher Scientific Inc., among others. These companies contribute to advancements in healthcare by developing technologies and solutions that support research, clinical applications, and patient care, influencing the ongoing evolution of the global health sector.

• In December 2025, Cipla partnered with Stempeutics to launch Ciplostem, an allogeneic mesenchymal stromal cell (MSC) therapy for Knee Osteoarthritis (Knee OA), recently approved by the Drug Controller General of India (DCGI). This innovative treatment targets Grade II and III Knee OA, addressing a significant gap in disease-modifying options as current therapies mainly focus on temporary relief. Ciplostem consists of a single intra-articular injection containing 25 million cultured adult bone marrow-derived MSCs and hyaluronic acid, aimed at reducing inflammation and pain while improving joint function and cartilage quality.
• In August 2025, the IAEA launched a new stem cell research project aimed at improving healing for patients with severe radiation skin injuries. Radiation damage can lead to painful and debilitating skin complications that impact quality of life. This coordinated research project will investigate the potential of specific types of stem cells to develop regenerative therapies, addressing the complex needs of these patients that current therapies do not fully meet.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Cell Type
  • By Application
  • By Technology
  • By Therapy Type
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Lonza Group, Merck KGaA, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Stem Cells Market Report Segment

By Cell Type

• Adult Stem Cells
• Human Embryonic Stem Cells (hESCs)
• Induced Pluripotent Stem Cells (iPSCs)
• Others

By Application

• Regenerative Medicine / Therapeutic Use
• Emergen Research
• Drug Discovery & Development
• Research

By Technology

• Cell Acquisition
• Cell Typeion
• Cryopreservation
• Expansion & Sub?culture

By Therapy Type

• Allogeneic
• Autologous

By End User

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

Global Stem Cells Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/stem-cell-and-platelet-rich-plasma-alopecia-therapies-market